Publicaciones (19) Publicaciones de MOHAMED AHMED AHMED MASHAL

2024

  1. Expanding the horizon of transient CAR T therapeutics using virus-free technology

    Biotechnology Advances, Vol. 72

2023

  1. Bektore ez-biral lipidikoak garatzeko erabiltzen diren teknikak eta hauen garrantzia etorkizunerako

    Osasun zientziak: V. Ikergazte Nazioarteko Ikerteta Euskaraz. 2023eko maitzaren 17, 18 eta 19 Donostia, Euskal Herria.

  2. Stability of polymeric cationic niosomes and their plasmid DNA-based complexes as gene delivery carriers

    Drug Delivery, Vol. 30, Núm. 1

  3. Stem Cell-Derived Extracellular Vesicles as a Potential Therapeutic Tool for Eye Diseases: From Benchtop to Bedside

    Advances in experimental medicine and biology, Vol. 1410, pp. 127-143

2022

  1. Cell-based therapy for the treatment of glioblastoma: An update from preclinical to clinical studies

    Cells, Vol. 11, Núm. 1

  2. The use of cerium oxide nanoparticles in liver disorders: A double-sided coin?

    Basic and Clinical Pharmacology and Toxicology, Vol. 130, Núm. 3, pp. 349-363

2021

  1. Insights into the potential role of alpha1-antitrypsin in COVID-19 patients: Mechanisms, current update, and future perspectives

    Clinical Respiratory Journal

  2. Mesenchymal Stem Cells: The Past Present and Future

    Advances in Experimental Medicine and Biology (Springer), pp. 107-129

  3. Mesenchymal stem cells as a gene delivery tool: Promise, problems, and prospects

    Pharmaceutics, Vol. 13, Núm. 6

2019

  1. Cationic niosome-based hBMP7 gene transfection of neuronal precursor NT2 cells to reduce the migration of glioma cells in vitro

    Journal of Drug Delivery Science and Technology, Vol. 53

  2. Cationic niosomes as non-viral vehicles for nucleic acids: Challenges and opportunities in gene delivery

    Pharmaceutics, Vol. 11, Núm. 2

  3. Gene delivery to the rat retina by non-viral vectors based on chloroquine-containing cationic niosomes

    Journal of Controlled Release, Vol. 304, pp. 181-190

2018

  1. Gene transfer to rat cerebral cortex mediated by polysorbate 80 and poloxamer 188 nonionic surfactant vesicles

    Drug Design, Development and Therapy, Vol. 12, pp. 3937-3949

  2. Non-viral vectors based on cationic niosomes as efficient gene delivery vehicles to central nervous system cells into the brain

    International Journal of Pharmaceutics, Vol. 552, Núm. 1-2, pp. 48-55

  3. Stem cell-based gene delivery mediated by cationic niosomes for bone regeneration

    Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 14, Núm. 2, pp. 521-531

2017

  1. Retinal gene delivery enhancement by lycopene incorporation into cationic niosomes based on DOTMA and polysorbate 60

    Journal of Controlled Release, Vol. 254, pp. 55-64

2016

  1. Elaboration and physicochemical characterization of niosome-based nioplexes for gene delivery purposes

    Methods in Molecular Biology (Humana Press Inc.), pp. 63-75

2015

  1. Protamine/DNA/niosome ternary nonviral vectors for gene delivery to the retina: The role of protamine

    Molecular Pharmaceutics, Vol. 12, Núm. 10, pp. 3658-3671

2014

  1. A novel cationic niosome formulation for gene delivery to the retina

    Journal of Controlled Release, Vol. 174, Núm. 1, pp. 27-36